>70 Percent of Ophthalmologists Have Adopted EHRs

Share this content:
>70 Percent of Ophthalmologists Have Adopted EHRs
>70 Percent of Ophthalmologists Have Adopted EHRs

THURSDAY, Jan. 4, 2018 (HealthDay News) -- More than 72 percent of ophthalmologists surveyed have adopted electronic health records (EHRs), although perceptions of EHR productivity outcomes are frequently negative, according to a study published online Dec. 28 in JAMA Ophthalmology.

Michele C. Lim, M.D., from the University of California, Davis, in Sacramento, and colleagues conducted a population-based study to examine the adoption rate and perceptions of financial and clinical outcomes of EHRs among U.S. ophthalmologists. A random sample of 2,000 ophthalmologists was sent a survey by e-mail; 348 ophthalmologists responded.

The researchers found that the adoption rate of EHRs was 72.1 percent among the surveyed ophthalmologists. The respondents felt that EHR use was correlated with a reduction in their net revenues and productivity and increases in practice costs. Eighty-three percent of those who attested for stage 1 of the EHR incentive program had already or were intending to attest to stage 2, while 9 percent had no plans.

"In comparison with two previous surveys of ophthalmologists, respondents had more negative perceptions of EHR productivity outcomes and effect on practice costs, although financial data were not collected in this survey to support these opinions," the authors write. "These negative perceptions suggest that more attention should be placed on improving the efficiency and usability of EHR systems."

Two authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »